Advertisement

Prevalence and behavioural risk factors for hepatitis B in Upper Dolpo, Nepal

  • Anna Sofia MennerEmail author
  • Hans-Tilmann Kinkel
  • Sameer Dixit
  • Audry Morrison
  • Burkhard Rieke
  • Thomas Küpper
Original Article

Abstract

Background

Nepal is a country of low endemicity for chronic hepatitis B, with a prevalence of 0.9%. However, in Dolpo District, a higher prevalence of hepatitis B virus (HBV) was reported in small samples, anecdotal reports and, recently, among pregnant women. We determined data on HBV endemicity and risk factors among people from Dolpo (Dolpopa).

Methods

We conducted a cross-sectional HBV prevalence study among two separate convenience samples of overall 524 Dolpopa, assessing HBV serology on a medical supply tour to Upper Dolpo (Group 1, n = 223) and assessing detailed HBV serology, markers for hepatitis D virus (HDV) and human immunodeficiency virus (HIV) coinfection, as well as a questionnaire-based survey of risk behaviour and alcohol consumption patterns in Dolpopa visiting the Dolpali “Winter Clinic” in Kathmandu (Group 2, n = 301).

Results

The overall prevalence of hepatitis B surface antigen (HBsAg) was 18.7% [95% confidence interval (CI) 15.6–22.3%]. HBsAg prevalence was independent of age group and gender, but was significantly higher in the settlements lining the trading route between Nepal and China. From the HBsAg-positive participants, 68.8% (95% CI 56.6–78.8%) also tested positive for hepatitis B e antigen (HBeAg). Viral load among HBeAg-positive samples ranged from 3.12 × 107 to 1.42 × 109 IU/mL. HDV and HIV coinfection was not found. Questionnaires confirmed that 92% had never used a condom and 27.6% showed a risky alcohol consumption pattern.

Conclusions

HBV prevalence in Dolpo is significantly higher than in the rest of Nepal. Targeted interventions are recommended to address liver and sexual health education, including the introduction of birth dose HBV vaccinations, HBV screening and HBV vaccinations for pregnant women in Dolpo.

Keywords

Hepatitis B Dolpo Nepal HIV Hepatitis D 

Notes

Acknowledgements

We would like to thank the patients and contributors from the Winter Clinic of the Dolpo Tulku Charitable Foundation for making this research project possible. Special thanks go to the Dolpo Tulku Lhama. We are also grateful for the assistance of Chime Lhamo, P.J. Neiger and Kevin Kopp from the medical supply tour to Upper Dolpo.

This study was privately funded by the authors.

On behalf of all authors, the corresponding author states that all persons gave their informed verbal and written consent prior to their inclusion in the study.

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

All procedures performed in the study involving human participants were in accordance with the ethical standards of the national research committee [National Health Research Council (NHRC) of Nepal with the study code 196/2013] and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM (2007) Systematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr 44(9):663–674PubMedGoogle Scholar
  2. Central Bureau of Statistics (2012) National Population and Housing Census 2011 (National Report). Government of Nepal. https://unstats.un.org/unsd/demographic-social/census/documents/Nepal/Nepal-Census-2011-Vol1.pdf. Accessed 16 Sep 2019
  3. Cornberg M, Protzer U, Petersen J et al (2011) Aktualisierung der S3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. Z Gastroenterol 49(7):871–930.  https://doi.org/10.1055/s-0031-1273462 CrossRefPubMedGoogle Scholar
  4. Cui Y, Jia J (2013) Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 28(Suppl 1):7–10.  https://doi.org/10.1111/jgh.12220 CrossRefPubMedGoogle Scholar
  5. Dwivedi M, Misra SP, Misra V et al (2011) Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 30(2):66–71.  https://doi.org/10.1007/s12664-011-0083-y CrossRefPubMedGoogle Scholar
  6. Fattovich G (2003) Natural history and prognosis of hepatitis B. Semin Liver Dis 23(1):47–58.  https://doi.org/10.1055/s-2003-37590 CrossRefPubMedGoogle Scholar
  7. Gift A, Morgan C, Anderson D, Toole M (2004) Alarming levels of hepatitis B virus detected among rural Tibetans. Trop Doct 34(3):156–157.  https://doi.org/10.1177/004947550403400310 CrossRefGoogle Scholar
  8. Graham S, Guy RJ, Cowie B et al (2013) Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis. BMC Infect Dis 13:403.  https://doi.org/10.1186/1471-2334-13-403 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Liang X, Bi S, Yang W et al (2009a) Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis 200(1):39–47.  https://doi.org/10.1086/599332 CrossRefPubMedGoogle Scholar
  10. Liang X, Bi S, Yang W et al (2009b) Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine 27(47):6550–6557.  https://doi.org/10.1016/j.vaccine.2009.08.048 CrossRefPubMedGoogle Scholar
  11. Lin CL, Kao JH, Chen BF, Chen PJ, Lai MY, Chen DS (2005) Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus. Clin Infect Dis 41(11):1576–1581.  https://doi.org/10.1086/497837 CrossRefPubMedGoogle Scholar
  12. Livingston SE, Simonetti JP, Bulkow LR et al (2007) Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 133(5):1452–1457.  https://doi.org/10.1053/j.gastro.2007.08.010 CrossRefPubMedGoogle Scholar
  13. Luitel NP, Jordans M, Murphy A, Roberts B, McCambridge J (2013) Prevalence and patterns of hazardous and harmful alcohol consumption assessed using the AUDIT among Bhutanese refugees in Nepal. Alcohol Alcohol 48(3):349–355.  https://doi.org/10.1093/alcalc/agt009 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Maclachlan JH, Cowie BC (2015) Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med 5:a021410.  https://doi.org/10.1101/cshperspect.a021410 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Maddrey WC (2000) Hepatitis B: an important public health issue. J Med Virol 61:362–366.  https://doi.org/10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I CrossRefPubMedGoogle Scholar
  16. Mai K (1989) Study on Hepatitis Delta virus infection in China. Zhonghua Liu Xing Bing Xue Za Zhi 10(1):21–23PubMedGoogle Scholar
  17. Manandhar K, Shrestha B (2000) Prevalence of HBV infection among the healthy Nepalese males: a serological survey. J Epidemiol 10(6):410–413CrossRefGoogle Scholar
  18. McMahon BJ (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49(S5):S45–S55.  https://doi.org/10.1002/hep.22898 CrossRefPubMedGoogle Scholar
  19. Ochola E, Ocama P, Orach CG et al (2013) High burden of hepatitis B infection in Northern Uganda: results of a population-based survey. BMC Public Health 13(1):727.  https://doi.org/10.1186/1471-2458-13-727 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Ott JJ, Stevens GA, Wiersma ST (2012) The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions. BMC Infect Dis 12:131.  https://doi.org/10.1186/1471-2334-12-131 CrossRefPubMedPubMedCentralGoogle Scholar
  21. Pradhan B, Chappuis F, Baral D et al (2012) The alcohol use disorders identification test (AUDIT): validation of a Nepali version for the detection of alcohol use disorders and hazardous drinking in medical settings. Subst Abuse Treat Prev Policy 7(1):42.  https://doi.org/10.1186/1747-597X-7-42 CrossRefPubMedPubMedCentralGoogle Scholar
  22. Rex KF, Andersen S, Krarup HB (2015) Hepatitis B among Inuit: a review with focus on Greenland Inuit. World J Hepatol 7:1265–1271.  https://doi.org/10.4254/wjh.v7.i9.1265 CrossRefPubMedPubMedCentralGoogle Scholar
  23. Robinson T, Bullen C, Humphries W, Hornell J, Moyes C (2005) The New Zealand Hepatitis B Screening Programme: screening coverage and prevalence of chronic hepatitis B infection. N Z Med J 118(1211):U1345PubMedGoogle Scholar
  24. Rufai T, Mutocheluh M, Kwarteng K, Dogbe E (2014) The prevalence of hepatitis B virus E antigen among Ghanaian blood donors. Pan Afr Med J 17:53.  https://doi.org/10.11604/pamj.2014.17.53.3390 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Sharma BD, Booth K, Booth PB, Kenrick K (1981) Results of testing for HBsAg on Nepalese blood donors by counterimmunoelectrophoresis. J Nep Med Assoc 19:1Google Scholar
  26. Shedain PR, Joshi AB, Bhattarai KD (2006) Himalayan seasonal migration and STI/HIV infection: a case study among seasonal migrants in Kathmandu from Dolpa District, Nepal. J Nepal Health Res Counc 4(1):46–50Google Scholar
  27. Shedain PR, Devkota MD, Banjara MR, Ling H, Dhital S (2017) Prevalence and risk factors of hepatitis B infection among mothers and children with hepatitis B infected mother in upper Dolpa, Nepal. BMC Infect Dis 17(1):667CrossRefGoogle Scholar
  28. Shi YH (2012) Correlation between hepatitis B virus genotypes and clinical outcomes. Jpn J Infect Dis 65(6):476–482.  https://doi.org/10.7883/yoken.65.476 CrossRefPubMedGoogle Scholar
  29. Shrestha SM, Shrestha S (2012) Chronic hepatitis B in Nepal: an Asian country with low prevalence of HBV infection. Trop Gastroenterol 33(2):95–101CrossRefGoogle Scholar
  30. Shrestha S, Tsuda F (1991) Hepatitis Delta virus infection in Nepal. Trop Gastroenterol 12(4):185–187PubMedGoogle Scholar
  31. Shrestha SM, Takeda N, Tsuda F, Okamoto H, Shrestha S, Shrestha VM (2002) High prevalence of hepatitis B virus infection amongst Tibetans in Nepal. Trop Gastroenterol 23:63–65PubMedGoogle Scholar
  32. UNAIDS (2018) Nepal: HIV and AIDS estimates (2018). https://www.unaids.org/en/regionscountries/countries/nepal. Accessed 16 Sep 2019
  33. World Gastroenterology Organisation (2015) World Gastroenterology Organisation practice guideline. Hepatitis B. https://www.worldgastroenterology.org/guidelines/global-guidelines/hepatitis-b/hepatitis-b-english. Accessed 16 Sep 2019
  34. World Health Organization (WHO) (2002) Hepatitis B. WHO, Department of Communicable Diseases Surveillance and Response. https://apps.who.int/iris/bitstream/handle/10665/67746/WHO_CDS_CSR_LYO_2002.2_HEPATITIS_B.pdf?sequence=1. Accessed 16 Sep 2019
  35. World Health Organization (WHO) (2009) Hepatitis B vaccines: WHO position paper—recommendations. Vaccine 28(3):589–590.  https://doi.org/10.1016/j.vaccine.2009.10.110 CrossRefGoogle Scholar
  36. World Health Organization (WHO) (2014) Global status report on alcohol and health 2014. https://www.who.int/substance_abuse/publications/alcohol_2014/en. Accessed 16 Sep 2019
  37. World Health Organization (WHO) (2019) Hepatitis B fact sheet 2019. https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b. Accessed 16 Sep 2019
  38. World Health Organization Western Pacific Regional Office (WPRO) (2019) Hepatitis B control in China 2018. http://www.wpro.who.int/china/mediacentre/factsheets/hepatitis/en. Accessed 16 Sep 2019
  39. Zhao SM, Li HC, Lou H et al (2001) High prevalence of HBV in Tibet, China. Asian Pac J Cancer Prev 2(4):299–304PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Diabetology and EndocrinologyMedicover Berlin-MitteBerlinGermany
  2. 2.Department for Occupational and Social MedicineRWTH Aachen UniversityAachenGermany
  3. 3.Dolpo Tulku Charitable FoundationKathmanduNepal
  4. 4.Center for Molecular Dynamics NepalKathmanduNepal
  5. 5.Royal Free London NHS Foundation TrustLondonUK

Personalised recommendations